Cereblon regulates the production of hepatic fibroblast growth factor 23 in diabetes

키워드

참고문헌 (38)

1. Higgins JJ, "A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation", Neurology, 63, pp.1927~1931 (2004)
2. Higgins JJ, "Dysregulation of large-conductance Ca2＋-activated K＋ channel expression in nonsyndromal mental retardation due to a cereblon p. R419X mutation", Neurogenetics, 9, pp.219~223 (2008)
3. Kim HK, "Cereblon in health and disease", Pflugers Arch, 468, pp.1299~1309 (2016)
4. Lee KM, "Disruption of the cereblon gene enhances hepatic AMPK activity and prevents high-fat diet-induced obesity and insulin resistance in mice", Diabetes, 62, pp.1855~1864 (2013)
5. Jo JR, "Gluconeogenic signals regulate hepcidin gene expression via a CRBN-KLF15 axis", BMB Rep, 54, pp.221~226 (2021)
6. Thakurta A, "Absence of mutations in cereblon(CRBN)and DNA damage-binding protein 1(DDB1)genes and significance for IMiD therapy", Leukemia, 28, pp.1129~1131 (2014)
7. Dann GP, "Cereblon target validation using a covalent inhibitor of neosubstrate recruitment", Methods Enzymol, 681, pp.155~167 (2023)
8. Watson ER, "Molecular glue CELMoD compounds are regulators of cereblon conformation", Science, 378, pp.549~553 (2022)
9. Perwad F, "Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro", Am J Physiol Renal Physiol, 293, pp.F1577~1583 (2007)
10. Gutierrez OM, "Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease : updating the trade-off hypothesis", Clin J Am Soc Nephrol, 5, pp.1710~1716 (2010)
11. Nakatani S, "Fibroblast growth factor 23 as regulator of vitamin D metabolism", Adv Exp Med Biol, 1362, pp.47~54 (2022)
12. Clinkenbeard EL, "Systemic control of bone homeostasis by FGF23 signaling", Curr Mol Biol Rep, 2, pp.62~71 (2016)
13. Razzaque MS, "FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player?", Am J Physiol Renal Physiol, 296, pp.F470~476 (2009)
14. Shimada T, "Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism", J Clin Invest, 113, pp.561~568 (2004)
15. Hesse M, "Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice", Matrix Biol, 26, pp.75~84 (2007)
16. Wojcik M, "The association of FGF23levels in obese adolescents with insulin sensitivity", J Pediatr Endocrinol Metab, 25, pp.687~690 (2012)
17. Garland JS, "Insulin resistance is associated with fibroblast growth factor-23 in stage 3-5 chronic kidney disease patients", J Diabetes Complications, 28, pp.61~65 (2014)
18. Hanks LJ, "Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults", PLoS One, 10, pp.e0122885~ (2015)
19. Nakashima A, "Association between resistin and fibroblast growth factor 23 in patients with type 2 diabetes mellitus", Sci Rep, 8, pp.13999~ (2018)
20. Donate-Correa J, "Pathophysiological implications of imbalances in fibroblast growth factor 23 in the development of diabetes", J Clin Med, 10, pp.2583~ (2021)
21. Rausch S, "The regulation of FGF23under physiological and pathophysiological conditions", Pflugers Arch, 474, pp.281~292 (2022)
22. van der Vaart A, "Fibroblast growth factor 23, glucose homeostasis, and incident diabetes : findings of 2cohort studies", J Clin Endocrinol Metab, 108, pp.e971~978 (2023)
23. Thomas MJ, "Unlocking the mechanisms of transcription factor YY1 : are chromatin modifying enzymes the key?", Gene, 236, pp.197~208 (1999)
24. Gordon S, "Transcription factor YY1 : structure, function, and therapeutic implications in cancer biology", Oncogene, 25, pp.1125~1142 (2006)
25. Lee SE, "B-cell translocation gene 2 promotes hepatic hepcidin production via induction of Yin Yang 1", Biochem Biophys Res Commun, 460, pp.996~1001 (2015)
26. Lu Y, "Yin Yang 1 promotes hepatic gluconeogenesis through upregulation of glucocorticoid receptor", Diabetes, 62, pp.1064~1073 (2013)
27. Blattler SM, "Yin Yang 1 deficiency in skeletal muscle protects against rapamycin-induced diabetic-like symptoms through activation of insulin", IGF signaling, 2012, pp.15, 505~517
28. Shi J, "The role of YY1in oncogenesis and its potential as a drug target in cancer therapies", Curr Cancer Drug Targets, 15, pp.145~157 (2015)
29. Lu Y, "Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice", Gut, 63, pp.170~178 (2014)
30. Lee SE, "Induction of SIRT1 by melatonin improves alcohol-mediated oxidative liver injury by disrupting the CRBN-YY1-CYP2E1 signaling pathway", J Pineal Res, 68, pp.e12638~ (2020)
31. Jo JR, "Growth hormone promotes hepatic gluconeogenesis by enhancing BTG2-YY1 signaling pathway", Sci Rep, 11, pp.18999~ (2021)
32. Marchelek-Mysliwiec M, "Association of FGF19, FGF21 and FGF23 with carbohydrate metabolism parameters and insulin resistance in patients with chronic kidney disease", J Appl Biomed, 18, pp.61~69 (2020)
33. Nakashima A, "Role and treatment of insulin resistance in patients with chronic kidney disease : a review", Nutrients, 13, pp.4349~ (2021)
34. Rossaint J, "FGF23signaling impairs neutrophil recruitment and host defense during CKD", J Clin Invest, 126, pp.962~974 (2016)
35. Nemeth E, "IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin", J Clin Invest, 113, pp.1271~1276 (2004)
36. Guo YC, "Fibroblast growth factor 23and bone mineralisation", Int J Oral Sci, 7, pp.8~13 (2015)
37. El-Hodhod MA, "Fibroblast growth factor 23 contributes to diminished bone mineral density in childhood inflammatory bowel disease", BMC Gastroenterol, 12, pp.44~ (2012)
38. Park S, "Long-term depletion of cereblon induces mitochondrial dysfunction in cancer cells", BMB Rep, 54, pp.305~310 (2021)

관련 논문AI추천